These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7859591)

  • 1. Pathophysiology and pathogenesis of visceral fat obesity.
    Matsuzawa Y; Shimomura I; Nakamura T; Keno Y; Tokunaga K
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S111-6. PubMed ID: 7859591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and pathogenesis of visceral fat obesity.
    Matsuzawa Y; Shimomura I; Nakamura T; Keno Y; Kotani K; Tokunaga K
    Obes Res; 1995 Sep; 3 Suppl 2():187S-194S. PubMed ID: 8581775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology and pathogenesis of visceral fat obesity.
    Matsuzawa Y; Shimomura I; Nakamura T; Keno Y; Tokunaga K
    Ann N Y Acad Sci; 1995 Jan; 748():399-406. PubMed ID: 7695182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance and body fat distribution.
    Yamashita S; Nakamura T; Shimomura I; Nishida M; Yoshida S; Kotani K; Kameda-Takemuara K; Tokunaga K; Matsuzawa Y
    Diabetes Care; 1996 Mar; 19(3):287-91. PubMed ID: 8742584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity.
    Fujioka S; Matsuzawa Y; Tokunaga K; Kawamoto T; Kobatake T; Keno Y; Kotani K; Yoshida S; Tarui S
    Int J Obes; 1991 Dec; 15(12):853-9. PubMed ID: 1794928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance.
    Kabir M; Catalano KJ; Ananthnarayan S; Kim SP; Van Citters GW; Dea MK; Bergman RN
    Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E454-61. PubMed ID: 15522994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Obesity and insulin resistance syndrome].
    Tokunaga K; Matsuzawa Y
    Nihon Rinsho; 1996 Oct; 54(10):2679-86. PubMed ID: 8914427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The free testosterone to dehydroepiandrosterone sulphate molar ratio as a marker of visceral fat accumulation in premenopausal obese women.
    De Pergola G; Triggiani V; Giorgino F; Cospite MR; Garruti G; Cignarelli M; Guastamacchia E; Giorgino R
    Int J Obes Relat Metab Disord; 1994 Oct; 18(10):659-64. PubMed ID: 7866460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral fat accumulation and cardiovascular disease.
    Matsuzawa Y; Nakamura T; Shimomura I; Kotani K
    Obes Res; 1995 Dec; 3 Suppl 5():645S-647S. PubMed ID: 8653544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of visceral fat syndrome in pathogenesis of impaired glucose tolerance].
    Nakamura T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():246-9. PubMed ID: 15779380
    [No Abstract]   [Full Text] [Related]  

  • 11. Sex differences in visceral fat lipolysis and metabolic complications of obesity.
    Lönnqvist F; Thörne A; Large V; Arner P
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1472-80. PubMed ID: 9261282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity.
    Matsuura F; Yamashita S; Nakamura T; Nishida M; Nozaki S; Funahashi T; Matsuzawa Y
    Metabolism; 1998 Aug; 47(8):929-33. PubMed ID: 9711987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral fat and insulin resistance--causative or correlative?
    Frayn KN
    Br J Nutr; 2000 Mar; 83 Suppl 1():S71-7. PubMed ID: 10889795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.
    Wajchenberg BL
    Endocr Rev; 2000 Dec; 21(6):697-738. PubMed ID: 11133069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effects of body fat distribution on glucose tolerance in overweight subjects: glucose intolerance and insulin resistance induced by intra-abdominal fat accumulation].
    Yanagisawa K
    Nihon Naibunpi Gakkai Zasshi; 1991 Nov; 67(11):1240-51. PubMed ID: 1761138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intra-abdominal visceral fat in myotonic dystrophy].
    Nozaki S; Miyai I; Kang J
    Rinsho Shinkeigaku; 1992 May; 32(5):521-3. PubMed ID: 1458730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed post-prandial lipid metabolism in subjects with intra-abdominal visceral fat accumulation.
    Taira K; Hikita M; Kobayashi J; Bujo H; Takahashi K; Murano S; Morisaki N; Saito Y
    Eur J Clin Invest; 1999 Apr; 29(4):301-8. PubMed ID: 10231342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of metabolically benign obesity in humans.
    Stefan N; Kantartzis K; Machann J; Schick F; Thamer C; Rittig K; Balletshofer B; Machicao F; Fritsche A; Häring HU
    Arch Intern Med; 2008 Aug; 168(15):1609-16. PubMed ID: 18695074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin resistance syndrome, visceral fat syndrome].
    Nakamura T; Matsuzawa Y
    Nihon Rinsho; 1997 Nov; 55 Suppl():792-8. PubMed ID: 9434566
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between visceral fat accumulation and anti-lipolytic action of insulin in patients with type 2 diabetes mellitus.
    Kurioka S; Murakami Y; Nishiki M; Sohmiya M; Koshimura K; Kato Y
    Endocr J; 2002 Aug; 49(4):459-64. PubMed ID: 12402978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.